Atlas Trials

PET Imaging of 68Ga-Her2-affibody in Tumors with High Her2 Expression

Clinical trial NCT06289517 · RECRUITING

Trial details

NCT number
NCT06289517
Sponsor
Peking University First Hospital
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Neoplasms
Start date
2024-05-28
Primary completion
2025-07-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.